Pet Diabetes Care Devices Market Is Estimated To Witness High Growth Owing To Rising Pet Obesity Rates

  • Ronak Shah
  • U.S.A
  • January 14, 2025

The Pet Diabetes Care Devices Market is estimated to be valued at US$ 2.42 Bn in 2024 and is expected to exhibit a CAGR of 7.1% over the forecast period 2024-2031, as highlighted in a new report published by Coherent Market Insights’The growth of the pet diabetes care devices market is majorly driven by the rising pet obesity rates across the globe.

Sedentary lifestyle of pets and high calorie diets are contributing significantly to the obesity problem among pets. According to recent survey, over 50% of cats and dogs in the U.S. are overweight or obese. Obese pets are at high risk of developing diabetes. Thus, rising pet obesity rates are creating high demand for pet diabetes care devices such as glucose monitoring devices and insulin delivery devices for effective management of diabetes among pets. In addition, growing awareness among pet owners regarding diabetes care and management is another major factor propelling the market growth.

Key Market Trends: Non-invasive glucose monitoring devices and wearable insulin pumps are the major trends gaining traction in the pet diabetes care devices market. The availability of non-invasive blood glucose monitoring devices that do not require drawing blood sample from pets is catalyzing the market growth. For instance, IDension developed Glucolizer, a non-invasive blood glucose monitor that uses infrared light technology for measuring blood glucose level of dogs and cats. Similarly, advancements in wearable insulin pumps with improved adherence and ease of use are augmenting the demand. For instance, in 2020, Companion Medical launched InPen, the first FDA approved smart insulin pen exclusively for diabetic dogs and cats.

Pet Diabetes Care Devices Market Opportunity: By Animal Type Insights-The canine segment held the largest market share of over 60% in 2019 owing to the high incidence of canine diabetes. Canines are more prone to developing diabetes than other pets due to factors such as obesity from overeating and lack of exercise. The feline segment is expected to witness the fastest growth during the forecast period owing to the rising pet ownership of cats and increasing awareness about feline diabetes.

By Solution Insights-Insulin delivery devices dominated the market in 2019 with a share of over 55% owing to their widespread use for effective management of diabetes in pets. The blood glucose monitoring solutions segment is anticipated to witness the highest growth during the forecast period owing to the development of user-friendly monitoring devices by key players and growing adoption of these devices for keeping track of blood glucose levels in diabetic pets.

Key Market Takeaways: The pet diabetes care devices market size was valued at USD 2.42 Bn in 2024 and is anticipated to witness a CAGR of 7.1% during the forecast period 2024-2031. This can be attributed to the increasing incidence of diabetes in pets coupled with rising pet ownership and growing pet healthcare expenditure.

On the basis of animal type, the canine segment is expected to hold a dominant position owing to the high prevalence of diabetes in dogs. Feline diabetes cases are also on the rise, which will drive the growth of the feline segment during the forecast period.

Based on solutions, insulin delivery devices accounted for over half of the market share in 2019. However, blood glucose monitoring solutions are poised to witness stronger growth due to the availability of user-friendly and affordable monitoring kits.

Regionally, North America dominated the pet diabetes care devices market in 2019 due to favorable pet healthcare industry outlook and rising per capita pet expenditure in the region.

Competitor Insights: Some of the prominent players operating in the pet diabetes care devices market include Virbac, Medtronic Plc, TaiDoc Technology Corporation, and GlySens Incorporated. These players are focusing on developing advanced and affordable solutions to boost their market share.

Recent Developments: In July 2023 was the launch of new pre-filled insulin pens specifically designed for pets with diabetes. Available in both low and high dose options, these pens make administering insulin much more convenient compared to traditional syringes. They eliminate the need to draw insulin from bottles or vials using needles. The doses can also be easily adjusted based on a pet’s needs. This is expected to improve compliance for diabetes management among pet owners. More information in full report.

Summary

TDS NEWS